ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test
Introduction
The ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test is a specialized genetic test designed to identify mutations in the ATP1A2 gene, which is associated with a rare neurological disorder known as alternating hemiplegia of childhood (AHC). This condition is characterized by recurrent episodes of paralysis that can affect one side of the body, leading to significant challenges in mobility and daily functioning.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to detect specific mutations in the ATP1A2 gene. By analyzing the genetic material, healthcare professionals can determine whether a patient has inherited a mutation that may contribute to the development of AHC.
Who Should Consider This Test
Parents or guardians of children exhibiting symptoms such as recurrent unilateral paralysis, developmental delays, or unexplained neurological episodes should consider this test. Family history of neurological disorders or known mutations in the ATP1A2 gene also warrants testing.
Benefits of Taking the Test
- Early diagnosis of alternating hemiplegia of childhood can lead to timely medical interventions.
- Understanding the genetic basis of the disorder helps in better management and treatment planning.
- Provides valuable information for family planning and genetic counseling.
Understanding Your Results
Results from the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test will be interpreted by qualified genetic counselors and neurologists. A positive result indicates the presence of a mutation, while a negative result suggests that no known mutations were detected. It is essential to discuss the implications of the results with a healthcare provider.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking the Test
To book the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test, please contact us at +2348077798758 or visit our website. Ensure you have a clinical history of the patient ready and consider a genetic counselling session to discuss the family history related to AHC.
Test Details
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
- Pre-Test Instructions: Clinical history of the patient and genetic counselling session to draw a pedigree chart of family members affected with ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1.
For more information and to take the next step towards understanding your child’s health, contact us today!
